-
Loading metrics
First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors
- Klaus Mross,
- Heike Richly,
- Richard Fischer,
- Dirk Scharr,
- Martin Büchert,
- Angelika Stern,
- Hendrik Gille,
- Laurent P. Audoly,
- Max E. Scheulen
x
- Published: December 13, 2013
- https://doi.org/10.1371/journal.pone.0083232